SECOND SIGHT MEDICAL PRODUCTS, INC. (NASDAQ:EYES) Files An 8-K Regulation FD Disclosure
ITEM 7.01. REGULATION FD DISCLOSURE
Second Sight Medical Products, Inc. (“Second Sight” or the “Company”), will make presentations at investment conferences as described in Item 8.01 below (“Conferences”). A copy of a slide presentation that Will McGuire, President and Chief Executive Officer and John Blake, Chief Financial Officer, intend to use (the “Presentation Materials”) during the Conferences is attached to this Current Report on Form 8-K as Exhibit 99.1, and is incorporated by reference herein. The Presentation Materials speak as of the date of this Current Report on Form 8-K. While Second Sight may elect to update the Presentation Materials in the future or reflect events and circumstances occurring or existing after the date of this Current Report on Form 8-K, Second Sight specifically disclaims any obligation to do so. The information contained in this Item 7.01 and Exhibit 99.1 hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by reference in such a filing.
ITEM 8.01 Other Events
Will McGuire, President and Chief Executive Officer and John Blake, Chief Financial Officer, will make presentations as follows:
Conference:2019 Wells Fargo Healthcare Conference
Date:Wednesday, September 4, 2019
Time:3:00 P.M. Eastern Daylight Time
Location:Westin Copley Place, Boston, MA
Webcast:https://cc.talkpoint.com/well001/090419a_js/?entity=79_DOKDK3H
Presenter: Will McGuire, Chief Executive Officer
The Wells Fargo presentation will be webcast live at the aforementioned time and will be archived for 30 days thereafter, via the Company’s website at www.secondsight.com, under the Investors Section.
Conference:4th Annual Dougherty & Company Institutional Investor Conference
Date:Thursday, September 5, 2019
Location:Millennium Hotel, Minneapolis, MN
Event format:1×1 meetings
Presenter:John Blake, Chief Financial Officer
Conference:H.C. Wainwright 21st Annual Global Investment Conference
Date:Monday, September 9, 2019
Time:2:10 P.M. Eastern Daylight Time
Location:Lotte New York Palace Hotel, New York, NY
Presenter: Will McGuire, Chief Executive Officer
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
Exhibit No. Description
99.1 Presentation Materials dated September 4, 2019.
SECOND SIGHT MEDICAL PRODUCTS INC Exhibit
EX-99.1 2 eyes-ex991_6.htm EX-99.1 eyes-ex991_6.pptx.htm Second Sight Medical Products,…
To view the full exhibit click here
About SECOND SIGHT MEDICAL PRODUCTS, INC. (NASDAQ:EYES)
Second Sight Medical Products, Inc. is engaged in developing, manufacturing and marketing prosthetic devices that restore vision to blind individuals. The Company’s product, the Argus II System, treats outer retinal degenerations, such as retinitis pigmentosa (RP). The Argus II System provides an artificial form of vision that differs from the vision of people with normal sight. It does not restore normal vision and it does not slow or reverse the progression of the disease. The Company’s Argus II System employs electrical stimulation to bypass degenerated photoreceptor cells and to stimulate remaining viable retinal cells thereby inducing visual perception in blind individuals. The Argus II System works by converting video images captured by a miniature camera housed in a patient’s glasses into a series of small electrical pulses that are transmitted wirelessly to an array of electrodes that are implanted on the surface of the retina.
